Ryan Lynch
ASSOCIATE, CLINICAL
Ryan Lynch joined Sandbox in 2025 and is an Associate at the firm. Ryan serves as a Board Observer for Ultromics.
Ryan focuses on Sandbox's life science investing, specifically across medical devices, diagnostics, and AI/software products for clinicians.
Prior to Sandbox, Ryan worked in the MedTech and Life Sciences industry for five years at Becton Dickinson (BD), where he completed the Finance Leadership Development Program and later supported commercial strategy within the Biosciences division. He also interned at JJDC (Johnson & Johnson’s corporate venture arm) and Joyance Partners, gaining experience investing in medical devices, diagnostics, digital health, and healthcare services.
Ryan holds an MBA from the University of Chicago Booth School of Business and a BS in Accounting from Brigham Young University.
ASSOCIATE, CLINICAL
Ryan Lynch joined Sandbox in 2025 and is an Associate at the firm. Ryan serves as a Board Observer for Ultromics.
Ryan focuses on Sandbox's life science investing, specifically across medical devices, diagnostics, and AI/software products for clinicians.
Prior to Sandbox, Ryan worked in the MedTech and Life Sciences industry for five years at Becton Dickinson (BD), where he completed the Finance Leadership Development Program and later supported commercial strategy within the Biosciences division. He also interned at JJDC (Johnson & Johnson’s corporate venture arm) and Joyance Partners, gaining experience investing in medical devices, diagnostics, digital health, and healthcare services.
Ryan holds an MBA from the University of Chicago Booth School of Business and a BS in Accounting from Brigham Young University.
ASSOCIATE, CLINICAL
Ryan Lynch joined Sandbox in 2025 and is an Associate at the firm. Ryan serves as a Board Observer for Ultromics.
Ryan focuses on Sandbox's life science investing, specifically across medical devices, diagnostics, and AI/software products for clinicians.
Prior to Sandbox, Ryan worked in the MedTech and Life Sciences industry for five years at Becton Dickinson (BD), where he completed the Finance Leadership Development Program and later supported commercial strategy within the Biosciences division. He also interned at JJDC (Johnson & Johnson’s corporate venture arm) and Joyance Partners, gaining experience investing in medical devices, diagnostics, digital health, and healthcare services.
Ryan holds an MBA from the University of Chicago Booth School of Business and a BS in Accounting from Brigham Young University.